@article{TAU15623,
author = {Tanya Ha and Jie Hua Xu},
title = {Interstitial cystitis intravesical therapy},
journal = {Translational Andrology and Urology},
volume = {6},
number = {Suppl 2},
year = {2017},
keywords = {},
abstract = {Interstitial cystitis (IC) is a progressive bladder disorder that presents with symptoms of bladder urgency, frequency and pain. The aetiology of the disease remains uncertain, but it is postulated that there is an initial infective insult which damages the glycosaminoglycan (GAG) layer of the bladder urothelium. This defect allows an influx of ions, particularly potassium, which initiates an inflammatory reaction in the bladder wall, which incites the symptoms described above. Treatment initially involves behavioural and oral medication, with second line being intravesical instillation therapy. Treatment strategies focus on restoring lower urinary tract epithelial function, inhibiting neural activation, controlling allergies and relieving symptoms. In this review, current intravesical therapy will be discussed, as well as what lies on the horizon for intravesical therapy in IC.},
issn = {2223-4691}, url = {https://tau.amegroups.org/article/view/15623}
}